Evox Therapeutics has partnered with the University of Oxford's Harrington Rare Disease Centre to advance research projects for translational exosome therapeutics to treat rare diseases using the company's DeliverEX technology.
Evox Therapeutics, U. of Oxford enter research pact
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.